Publications

  1. Graham RP, Craig JR, Jin L, Oliveira AM, Bergquist JR, Truty MJ, Mounajjed T, Greipp PT, Torbenson MS. Environmental exposures as a risk factor for fibrolamellar carcinoma. Mod Pathol 2017 Jun; 30 (6):892-896 Epub 2017 Mar 03
    View PubMed
  2. Chen TY, Keeney MG, Chintakuntlawar AV, Knutson DL, Kloft-Nelson S, Greipp PT, Garrity JA, Salomao DR, Garcia JJ. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement. Eye (Lond) 2017 May; 31 (5):720-725 Epub 2017 Jan 13
    View PubMed
  3. Aesif SW, Aubry MC, Yi ES, Kloft-Nelson SM, Jenkins SM, Spears GM, Greipp PT, Sukov WR, Roden AC. Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas. J Thorac Oncol 2017 May; 12 (5):860-871 Epub 2017 Feb 05
    View PubMed
  4. Ertz-Archambault N, Kosiorek H, Slack JL, Lonzo ML, Greipp PT, Khera N, Kelemen K. Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival. Biol Blood Marrow Transplant 2017 May; 23 (5):782-789 Epub 2017 Feb 09
    View PubMed
  5. Ding W, LaPlant BR, Call TG, Parikh SA, Leis JF, He R, Shanafelt TD, Sinha S, Le-Rademacher J, Feldman AL, Habermann TM, Witzig TE, Wiseman GA, Lin Y, Asmus E, Nowakowski GS, Conte MJ, Bowen DA, Aitken CN, Van Dyke DL, Greipp PT, Liu X, Wu X, Zhang H, Secreto CR, Tian S, Braggio E, Wellik LE, Micallef I, Viswanatha DS, Yan H, Chanan-Khan AA, Kay NE, Dong H, Ansell SM. Pembrolizumab in patients with chronic lymphocytic leukemia with Richter's transformation and relapsed CLL. Blood 2017 Apr 19 [Epub ahead of print]
    View PubMed
  6. Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB. Diagnosis and Management of Waldenstrom Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. JAMA Oncol 2017 Jan 05 [Epub ahead of print]
    View PubMed
  7. Wang Y, Ding X, Wang S, Moser CD, Shaleh HM, Mohamed EA, Chaiteerakij R, Allotey LK, Chen G, Miyabe K, McNulty MS, Ndzengue A, Barr Fritcher EG, Knudson RA, Greipp PT, Clark KJ, Torbenson MS, Kipp BR, Zhou J, Barrett MT, Gustafson MP, Alberts SR, Borad MJ, Roberts LR. Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein. Cancer Lett 2016 Sep 28; 380 (1):163-73 Epub 2016 May 20
    View PubMed
  8. Boddicker RL, Razidlo GL, Dasari S, Zeng Y, Hu G, Knudson RA, Greipp PT, Davila JI, Johnson SH, Porcher JC, Smadbeck JB, Eckloff BW, Billadeau DD, Kurtin PJ, McNiven MA, Link BK, Ansell SM, Cerhan JR, Asmann YW, Vasmatzis G, Feldman AL. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma. Blood 2016 Sep 01; 128 (9):1234-45 Epub 2016 June 13
    View PubMed
  9. King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG, Howard MT. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. Am J Clin Pathol 2016 Jun; 145 (6):843-51 Epub 2016 June 21
    View PubMed
  10. He R, Greipp PT, Rangan A, Mai M, Chen D, Reichard KK, Nelsen LL, Pardanani A, Hanson CA, Viswanatha DS. BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia. Cancer Genet 2016 May; 209 (5):223-8 Epub 2016 Apr 06
    View PubMed
  11. Graham RP, Garcia JJ, Greipp PT, Barr Fritcher EG, Kipp BR, Torbenson MS. FGFR1 and FGFR2 in fibrolamellar carcinoma. Histopathology 2016 Apr; 68 (5):686-92 Epub 2015 Oct 05
    View PubMed
  12. Argyris PP, Wetzel SL, Greipp P, Wehrs RN, Knutson DL, Kloft-Nelson SM, Garcia JJ, Koutlas IG. Clinical utility of myb rearrangement detection and p63p40 immunophenotyping in the diagnosis of adenoid cystic carcinoma of minor salivary glands: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 2016 Mar; 121 (3):282-9 Epub 2015 Oct 19
    View PubMed
  13. Roden AC, Greipp PT, Knutson DL, Kloft-Nelson SM, Jenkins SM, Marks RS, Aubry MC, Garcia JJ. Histopathologic and Cytogenetic Features of Pulmonary Adenoid Cystic Carcinoma. J Thorac Oncol 2015 Nov; 10 (11):1570-5
    View PubMed
  14. Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Keeney GL, Nucci MR. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall. Int J Gynecol Pathol 2015 Nov; 34 (6):576-83
    View PubMed
  15. Schoolmeester JK, Greipp PT, Keeney GL, Soslow RA. Ovarian Hemangiomas Do Not Harbor EWSR1 Rearrangements: Clinicopathologic Characterization of 10 Cases. Int J Gynecol Pathol 2015 Sep; 34 (5):437-44
    View PubMed
  16. Graham RP, Jin L, Knutson DL, Kloft-Nelson SM, Greipp PT, Waldburger N, Roessler S, Longerich T, Roberts LR, Oliveira AM, Halling KC, Schirmacher P, Torbenson MS. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod Pathol 2015 Jun; 28 (6):822-9 Epub 2015 Feb 20
    View PubMed
  17. Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB. Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: Ultrastructural features and differential diagnosis. Ultrastruct Pathol. 2015; 39(1):69-77.
    View PubMed
  18. Kelemen K, Galani K, Conley CR, Greipp PT. Secondary Philadelphia chromosome and erythrophagocytosis in a relapsed acute myeloid leukemia after hematopoietic cell transplantation. Cancer Genet 2014 Jun; 207 (6):268-71 Epub 2014 June 10
    View PubMed
  19. Schoolmeester JK, Sciallis AP, Greipp PT, Hodge JC, Dal Cin P, Nucci MR, Keeney GL. MD MDM2 amplification in endometrial stromal tumors: a potential diagnostic pitfall. Accepted for publication, 07-03-2015. International Journal of Gynecological Pathology. 2014.
  20. Kelemen K, Galani K, Conley C, Greipp PT. Relapsed acute myeloid leukemia with secondary Philadelphia chromosome and erythrophagocytosis after hematopoietic cell transplantation. - In Press - 06-10-2014 Cancer Genetics.2014;
  21. Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol. 2014 Jan; 27(1):113-27. Epub 2013 Jul 05.
    View PubMed
  22. Schoolmeester JK, Greipp PT, Keeney GL, Soslow RA. Ovarian hemangiomas do not harbor EWSR1 rearrangements: Clinicopathologic characterization of 10 cases. International Journal of Gynecological Pathology. 2014 (in press).
  23. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol 2013 Nov; 163 (3):326-33 Epub 2013 Aug 27
    View PubMed
  24. Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC, Kumar S, Greipp PT. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc 2010 Oct; 85 (10):905-12 Epub 2010 July 15
    View PubMed
  25. Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol. 2008 Apr; 141(2):135-48. Epub 2008 Mar 03.
    View PubMed
  26. Greipp PT, Rajkumar V. Bortezomib: effective therapy for multiple myeloma targeting the ubiquitin-proteasome pathway. American Journal of Oncology Review. 2005 Jul; 4(7):468-71.
  27. Greipp PT, Dewald GW, Tefferi A. Prevalence, breakpoint distribution, and clinical correlates of t(5;12). Cancer Genet Cytogenet. 2004 Sep; 153(2):170-2.
    View PubMed